Urinary ACE2 in healthy adults and patients with uncomplicated type 1 diabetes

Canadian Journal of Physiology and Pharmacology

Volumn 92, Issue 8, 2014, Pages 703-706

  Cherney, David Z I ^a,b   Xiao, Fengxia ^c   Zimpelmann, Joseph ^c   Har, Ronnie L H ^a   Lai, Vesta ^a   Scholey, James W ^a   Reich, Heather N ^a   Burns, Kevin D ^c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Diabetes mellitus; Urinary ACE2

Indexed keywords

ACE PROTEIN, HUMAN; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; CASE CONTROL STUDY; COHORT ANALYSIS; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLISM; SECRETION (PROCESS); URINE;

ADULT; ANGIOTENSINOGEN; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; MALE; PEPTIDYL-DIPEPTIDASE A;

EID: 84905059947     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2014-0065     Document Type: Article

References (10)

1. Cherney, D.Z., Reich, H.N., Jiang, S., Har, R., Nasrallah, R., Hebert, R.L., et al. 2012. Hyperfiltration and the effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus. Am. J. Physiol. Regul. Integr.Comp.Physiol.303(7): R710-R718. doi:10.1152/ajpregu.00286.2012. PMID:22855276.
2. Mizuiri, S., Aoki, T., Hemmi, H., Arita, M., Sakai, K., and Aikawa, A. 2011. Urinary angiotensin-converting enzyme 2 in patients with CKD. Nephrology (Carlton), 16(6): 567-572. doi:10.1111/j.1440-1797.2011.01467.x. PMID:21457402.
3. Oudit, G.Y., Herzenberg, A.M., Kassiri, Z., Wong, D., Reich, H., Khokha, R., et al. 2006. Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. Am. J. Pathol. 168(6): 1808-1820. doi:10.2353/ajpath.2006.051091. PMID:16723697.
4. Oudit, G.Y., Liu, G.C., Zhong, J., Basu, R., Chow, F.L., Zhou, J., et al. 2010. Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes, 59(2): 529-538. doi:10.2337/db09-1218. PMID:19934006.
5. Park, S.E., Kim, W.J., Park, S.W., Park, J.W., Lee, N., Park, C.Y., and Youn, B.S. 2013. High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria. Eur. J. Endocrinol. 168(2): 203-210. doi:10.1530/EJE-12-0782. PMID:23144053.
6. Reich, H.N., Oudit, G.Y., Penninger, J.M., Scholey, J.W., and Herzenberg, A.M. 2008. Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int. 74(12): 1610-1616. doi:10.1038/ki.2008.497. PMID:19034303.
7. Sawaguchi, M., Araki, S.I., Kobori, H., Urushihara, M., Haneda, M., Koya, D., et al. 2012. Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitus. J. Diabetes Investig. 3(3): 318-324. doi:10.1111/j.2040-1124.2011.00172.x. PMID:22822420.
8. Soler, M.J., Wysocki, J., and Batlle, D. 2013. ACE2 alterations in kidney disease. Nephrol. Dial. Transplant. 28(11): 2687-2697. doi:10.1093/ndt/gft320. PMID:23956234.
9. Wysocki, J., Garcia-Halpin, L., Ye, M., Maier, C., Sowers, K., Burns, K.D., and Batlle, D. 2013. Regulation of urinary ACE2 in diabetic mice. Am. J. Physiol. Renal hysiol. 305(4): F600-F611. doi:10.1152/ajprenal.00600.2012. PMID:23761674.
10. Xiao, F., Hiremath, S., Knoll, G., Zimpelmann, J., Srivaratharajah, K., Jadhav, D., et al. 2012. Increased urinary angiotensin-converting enzyme 2 in renal transplant atients with diabetes. PLoS One, 7(5): e37649. doi:10.1371/journal.pone.0037649. PMID:22629438.